Haiyan Xu - Publications, H-index & Citations

Haiyan Xu

Jilin University

32H指数

159论文数

3.5K被引数

收录论文 53

发表时间

First-line pyrotinib plus apatinib in advanced non-small cell lung cancer harboring HER2 mutations or amplification: a phase II trial 一线吡咯替尼联合阿帕替尼治疗携带HER2突变或扩增的晚期非小细胞肺癌：一项II期临床试验

Lung Cancer

IF4.4

2026-09-01

PREAI

Yang, Yaning; Jiang, Wenxin; Yang, Guangjian; Li, Weihua; Li, Junling; Hao, Xuezhi; Xing, Puyuan; Lei, Siyu; Wei, Fang; Tian, Linyan; Xu, Haiyan; Wang, Yan

The comprehensive detection of hemoglobinopathy variants via long-read sequencing 通过长读长测序对血红蛋白病变异体进行综合检测

Human Genomics

IF4.3

2026-08-14

OAAI

Jiale Xiang; Jiguang Peng; Xiangzhong Sun; Chen Jiang; Huiru Zhao; Yaya Guo; Haiyan Xu; Shanshan Gu; Haodong Ye; Long You; Xiaoyan Huang; Shiping Chen; Baosheng Zhu; Zhiyu Peng

Spatiotemporal variations of extreme climate and their effects on vegetation growth in the northern permafrost regions during 1982–2022 1982—2022年北方永冻土区极端气候的空间和时间变化及其对植被生长的影响

CATENA

IF5.7

2025-09-08

PREAI

Yunxia Dong; Guimin Liu; Xiaodong Wu; Lin Wang; Sizhong Yang; Tonghua Wu; Haiyan Xu; Evgeny Abakumov; Jun Zhao; Xingyuan Cui; Meiqi Shao

Mesenchymal stem cells and exosomes in ischemic brain injury: a review 间充质干细胞和外泌体在缺血性脑损伤中的作用：综述

Frontiers in Genetics

IF2.8

2025-08-29

OAAI

Haiyan Xu; Lanlan Yang; Weitie Wang; Chengwei Zhang

Dynamic characterization of circulating tumor DNA in HER2-altered advanced non-small cell lung cancer treated with pyrotinib and apatinib: Exploratory biomarker analysis from PATHER2 study HER2突变型晚期非小细胞肺癌患者接受吡咯替尼和阿帕替尼治疗后的循环肿瘤DNA动态表征：PATHER2研究中的探索性生物标志物分析

LUNG CANCER

IF4.4

2025-02-01

PREAI

Dong, Yucheng; Yang, Guangjian; Yang, Yaning; Zhang, Shuyang; Wang, Yan; Xu, Haiyan

KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors KEAP1突变是KRAS-G12C抑制剂耐药的关键预后生物标志物

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2025-01-17

OAAI

Tian, Linyan; Liu, Chengming; Zheng, Sufei; Shi, Huiyang; Wei, Fang; Jiang, Wenxin; Dong, Yucheng; Xu, Haiyan; Yin, Enzhi; Sun, Nan; He, Jie; Wang, Yan

UPDATE ON HIGH-GRADE GLIOMA PATIENTS TREATED WITH TTFIELDS FROM NANFANG HOSPITAL IN CHINA 中国南方医院接受ttfield治疗的高级别神经胶质瘤患者的最新情况

NEURO-ONCOLOGY

IF13.4

2024-11-11

PREAI

Zheng, Haojie; Que, Tianshi; Yi, Guozhong; Li, Zhiyong; Qu, Shanqiang; Zhang, Peidong; Yuan, Xi; Wang, Yajuan; Liu, Junlu; Nan, Jing; Liu, Ting; Xu, Haiyan; Qi, Songtao; Huang, Guanglong

Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme 多形性胶质母细胞瘤坏死性凋亡相关分子亚型的鉴定及坏死性凋亡相关基因标签的构建

CURRENT MEDICINAL CHEMISTRY

IF3.5

2024-10-01

PREAI

Li, Zhiyong; Jin, Yinghui; Que, Tianshi; Zhang, Xi-an; Yi, Guozhong; Zheng, Haojie; Yuan, Xi; Wang, Xiaoyan; Xu, Haiyan; Nan, Jing; Chen, Chao; Wu, Yuankui; Huang, Guanglong

VEGFA mediates traditional EGFR-TKI resistance in non-small cell lung cancer with EGFR exon 20 insertions VEGFA介导EGFR外显子20插入的非小细胞肺癌传统egfr-tki耐药

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Yang, Yaning; Liu, Chengming; Yang, Guangjian; Xu, Haiyan; Lei, Siyu; Wang, Yan

The potential of minimal residual disease (MRD) in guiding adjuvant therapy (AT) decisions in non-small cell lung cancer (NSCLC)

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Lei, Siyu; Xu, Haiyan; Yang, Yaning; Tian, Linyan; Ma, Ting; Wang, Yan

Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib

MOLECULAR CANCER

IF33.9

2024-03-08

OAAI

Ge, Weiyu; Wang, Yanling; Quan, Ming; Mao, Tiebo; Bischof, Evelyne Y.; Xu, Haiyan; Zhang, Xiaofei; Li, Shumin; Yue, Ming; Ma, Jingyu; Yang, Haiyan; Wang, Lei; Yu, Zhengyuan; Wang, Liwei; Cui, Jiujie

Developments in kidney xenotransplantation

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-01-11

OAAI

Xu, Haiyan; He, Xiaozhou

Immunotherapy as a later-line option for HER2-altered advanced non-small-cell lung cancer: taxane might be a favorable partner

FUTURE ONCOLOGY

IF2.6

2023-11-01

PREAI

Yang, Yaning; Yang, Guangjian; Li, Weihua; Xu, Haiyan; Hao, Xuezhi; Zhang, Shuyang; Ai, Xin; Lei, Siyu; Wang, Yan

Supramaximal resection based on en-bloc technique reduces tumor burden and prolongs survival in primary supratentorial lobar glioblastoma 基于整块技术的超最大切除术可减轻原发性幕上叶上胶质母细胞瘤的肿瘤负担并延长生存期

JOURNAL OF NEURO-ONCOLOGY

IF3.1

2023-10-02

PREAI

Que, Tianshi; Huang, Guanglong; Tan, Jian-er; Zhang, Peidong; Li, Zhiyong; Yi, Guozhong; Zheng, Haojie; Yuan, Xi; Xiao, Xiang; Liu, Junlu; Xu, Haiyan; Zhang, Xi-an; Qi, Songtao

Mutational landscape of SWI/SNF complex genes reveal correlation to predictive biomarkers for immunotherapy sensitivity in lung adenocarcinoma patients

ESMO OPEN

IF8.3

2023-06-01

OAAI

Xu, H.; Chen, H. -c.; Yang, L.; Yang, G.; Liang, L.; Yang, Y.; Tang, H.; Bao, H.; Wu, X.; Shao, Y.; An, G.; Wang, Y.

Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs 为不可避免的竞争充分利用现有武器-抵抗egfr-tkis

BIOMEDICINES

IF3.9

2023-04-10

OAAI

Li, Dongyu; Wang, Jingnan; Liu, Chengming; Luo, Yuejun; Xu, Haiyan; Wang, Yan; Sun, Nan; He, Jie

PLA2G2A+cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+cytotoxic T cells

CANCER LETTERS

IF10.1

2023-04-01

OAAI

Ge, Weiyu; Yue, Ming; Lin, Ruirong; Zhou, Tianhao; Xu, Haiyan; Wang, Yu; Mao, Tiebo; Li, Shumin; Wu, Xiuqi; Zhang, Xiaofei; Wang, Yongchao; Ma, Jingyu; Wang, Yanling; Xue, Shengbai; Shentu, Daiyuan; Cui, Jiujie; Wang, Liwei

Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-08-29

OAAI

Li, Hong-Shuai; Lei, Si-Yu; Li, Jun-Ling; Xing, Pu-Yuan; Hao, Xue-Zhi; Xu, Fei; Xu, Hai-Yan; Wang, Yan

Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2)Pyrotinib联合阿帕替尼靶向HER2改变的转移性非小细胞肺癌: 一项前瞻性，开放标签，单臂2期研究 (PATHER2)

BMC MEDICINE

IF8.3

2022-08-29

OAAI

Yang, Guangjian; Xu, Haiyan; Yang, Yaning; Zhang, Shuyang; Xu, Fei; Hao, Xuezhi; Li, Junling; Xing, Puyuan; Hu, Xingsheng; Liu, Yutao; Wang, Lin; Lin, Lin; Wang, Zhijie; Duan, Jianchun; Wang, Jie; Wang, Yan

Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils

BMC CANCER

IF3.4

2022-08-25

OAAI

Xu, Haiyan; Qi, Ziwei; Zhao, Qi; Xue, Jiao; Zhu, Jiaxing; He, Yan; Liu, Guirong; Qin, Songbing

研究方向